DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Preskorn SH, Baker B, Kolluri S. et al
An innovative design to establish proof of concept of the antidepressant effects of the NR 2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder.
J Clin Psychopharmacol 2008; 28: 631-637
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.